2Shaaban AM, Rezvani M. Imaging of primary fallopian tube carcinoma[J]. Abdom Imaging, 2013,38 (3) : 608- 618.
3Stewart SL, Wike JM, Foster SL, et al. The incidence of primary fallopian tube cancer in the United States[J]. Gynecol Oncol,2007,107 (3) : 392-397.
4Vicus D,Finch A,Cass I, et al. Prevalence of BRCA1 and BRCA2 germ line mutations among women with of carci- noma of the fallopian tube[J]. Gynecol Oncol, 2010,118 (3) :299-302.
5Domchek SM,Friebel TM, Garber JE, et al. Occult ovarian cancers identified at risk-reducing salpingo-oophorecto- my in a prospective cohort of BRCA1/2 mutation carriers [J]. Breast Cancer Res Treat, 2010,124(1) : 195-203.
6Nik NN, Vang R, Shih IM, et al. Origin and pathogenesis of pelvic(covarian, tubal and primary peritoneal) serous carcinoma[J]. Annu Rev Pathol Mech Dis, 2014,9 : 27-45.
7Ma Y,Duan W. Clinical and survival analysis of 36 cases of primary tube carcinoma[J]. World J Surg Oncol, 2014, 12(12) ;311-313.
8Sakurai N, Tateoka K, Fukaya K, et al. Supraclavicular lymph node metastasis as the initial presentation of pri- mary fallopian tube carcinoma[J]. Int J Clin Oneol, 2010, 15(3) : 301-304.
9Arko D, Zegura B, Virag M, et al. Preoperative diagnosis of fallopian tube malignancy with transvaginal color Doppler ultrasonography and magnetic resonance imaging after negative hysteroscopy for postmenopausal bleeding [J]. Coll Antropol, 2014,38 (3) :1047-1050.
10Shaaban AM, Rezvani M. Imaging of primary fallopian tube carcinoma[J]. Abdom Imaging, 2013, 38 (3): 608- 618.
